Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute Pancreatitis
JAMA Network Open · 28.06.2023 · 6 (6) · e2320802
DOI: 10.1001/jamanetworkopen.2023.20802 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 28.06.2023. Verfasst von Longxiang Cao und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Pancreatitis, Hyperlipidemias, Hypertriglyceridemia. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance The incidence of hypertriglyceridemia–associated acute pancreatitis (HTG-AP) is increasing. Plasmapheresis is theoretically effective in removing triglyceride from plasma, but whether it confers clinical benefits is unclear.
Objective
To assess the association between plasmapheresis and the incidence and duration of organ failure among patients with HTG-AP. Design, Setting, and Participants This is an a priori analysis of data from a multicenter, prospective cohort study with patients enrolled from 28 sites across China. Patients with HTG-AP were admitted within 72 hours from the disease onset. The first patient was enrolled on November 7th, 2020, and the last on November 30th, 2021. The follow-up of the 300th patient was completed on January 30th, 2022. Data were analyzed from April to May 2022. Exposures Receiving plasmapheresis. The choice of triglyceride-lowering therapies was at the discretion of the treating physicians. Main Outcomes and Measures The primary outcome was organ failure–free days to 14 days of enrollment. Secondary outcomes included other measures for organ failure, intensive care unit (ICU) admission, duration of ICU and hospital stays, incidence of infected pancreatic necrosis, and 60-day mortality. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) analyses were used to control potential confounders.
Results
Overall, 267 patients with HTG-AP were enrolled (185 [69.3%] were male; median [IQR] age, 37 [31-43] years), among whom 211 underwent conventional medical treatment and 56 underwent plasmapheresis. PSM created 47 pairs of patients with balanced baseline characteristics. In the matched cohort, no difference was detected concerning organ failure–free days between patients undergoing plasmapheresis or not (median [IQR], 12.0 [8.0-14.0] vs 13.0 [8.0-14.0]; P = .94). Moreover, more patients in the plasmapheresis group required ICU admission (44 [93.6%] vs 24 [51.1%]; P < .001). The IPTW results conformed to the results from the PSM analysis. Conclusions and Relevance In this large multicenter cohort study of patients with HTG-AP, plasmapheresis was commonly used to lower plasma triglyceride. However, after adjusting for confounders, plasmapheresis was not associated with the incidence and duration of organ failure, but with increased ICU requirements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
- National Institute of Healthcare Data Science, Nanjing University, Nanjing, China.
- Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Critical Care Medicine, Jinjiang Hospital of Traditional Chinese Medicine, Quanzhou, China.
- Department of Emergency Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, China.
- West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical Research Center, West China Hospital, Sichuan University, Chengdu, Chin…
Zitieren
APA
Cao, L., Chen, Y., Liu, S., Huang, W., Wu, D., Hong, D., Wang, Z., Sun, Y., Qin, K., Guo, F., Luo, C., Jiao, Q., Luo, X., Zhou, J., Li, G., Ye, B., Chen, T., Liu, M., Mao, W., …, & Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG) (2023). Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute Pancreatitis. JAMA Network Open, 6(6), e2320802. https://doi.org/10.1001/jamanetworkopen.2023.20802
Vancouver
Cao L, Chen Y, Liu S, Huang W, Wu D, Hong D, et al. Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute Pancreatitis. JAMA Network Open. 2023;6(6):e2320802. doi:10.1001/jamanetworkopen.2023.20802
BibTeX
@article{Cao2023,
author = {Cao, Longxiang and Chen, Yingjie and Liu, Siyao and Huang, Wei and Wu, Dong and Hong, Donghuang and Wang, Zuozheng and Sun, Yi and Qin, Kaixiu and Guo, Feng and Luo, Cuizhu and Jiao, Qinghai and Luo, Xiang and Zhou, Jing and Li, Gang and Ye, Bo and Chen, Tao and Liu, Man and Mao, Wenjian and Wang, Lanting and Li, Shuai and Windsor, John A and Liu, Yuxiu and Ke, Lu and Tong, Zhihui and Li, Weiqin and Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG), Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)},
title = {Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute Pancreatitis},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {6},
pages = {e2320802},
doi = {10.1001/jamanetworkopen.2023.20802}
}
EUVIMED